Company / Shares Outstanding
Minerva Neurosciences, Inc. Shares Outstanding History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
7.0M
FY2024
5-year range
5.3M / 42.7M
FY2020-FY2024
Trend
+31.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding returned to growth in FY2024 after 2 years of decline, reaching 6993406.00.
Based on SEC 10-K filings.
6993406.00 in FY2024 with a 5-year CAGR of -29.1%.
Increased from 5340196.00 to 6993406.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -45.3%
- 5-Year CAGR
- -29.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding increased 31.0% year-over-year.
- Peak shares outstanding was recorded in FY2021.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 7.0M | +31.0% |
| FY2023 | 5.3M | -0.0% |
| FY2022 | 5.3M | -87.5% |
| FY2021 | 42.7M | +9.3% |
| FY2020 | 39.1M | +0.4% |
| FY2019 | 38.9M | +0.5% |
| FY2018 | 38.7M | +10.6% |
| FY2017 | 35.0M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026